Literature DB >> 15953934

Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion.

F C Lowe1, J Batista, R Berges, E Chartier-Kastler, G Conti, F Desgrandchamps, K Dreikorn, M O'Leary, M Perez, M Speakman, J Trachtenberg, A Tubaro, B Meesen, L Smets, H Stoevelaar.   

Abstract

Disease progression has become an important issue for the management of lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH). Although several risk factors have been identified, no specific patient risk profiles have been established that can be useful in the day-to-day management of LUTS/BPH. In this study, an international panel of urologists developed a risk classification based on the attribution of a risk score to 243 unique patient profiles. From the perspective of clinical decision making, it was concluded that postvoid residual, symptom severity and maximum flow rate are the most relevant determinants of the risk of disease progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953934     DOI: 10.1038/sj.pcan.4500806

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  7 in total

Review 1.  Management of non-complicated BPH: proposition of a renewed decision tree.

Authors:  Francois Desgrandchamps; Alexandre de la Taille; Abdel-Rahmène Azzouzi; Marc Fourmarier; Olivier Haillot; Bertrand Lukacs; Christian Saussine
Journal:  World J Urol       Date:  2006-06-21       Impact factor: 4.226

Review 2.  [Epidemiology of benign prostatic syndrome. Associated risks and management data in German men over age 50].

Authors:  R Berges
Journal:  Urologe A       Date:  2008-02       Impact factor: 0.639

3.  Nocturia and its impact on health-related quality of life and health care seeking behaviour in German community-dwelling men aged 50 years or older.

Authors:  Matthias Oelke; Birgitt Wiese; Richard Berges
Journal:  World J Urol       Date:  2014-08-08       Impact factor: 4.226

4.  Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH).

Authors:  Michael A Kozminski; John T Wei; Jason Nelson; David M Kent
Journal:  BJU Int       Date:  2014-08-13       Impact factor: 5.588

5.  Epidemic investigation of benign prostatic obstruction with coexisting overactive bladder in Shanghai Pudong New Area and its impact on the health-related quality of life.

Authors:  Qing-Tong Yi; Min Gong; Chu-Hong Chen; Wei Hu; Ru-Jian Zhu
Journal:  BMC Urol       Date:  2019-09-03       Impact factor: 2.264

6.  Sociodemographic Factors Related to Lower Urinary Tract Symptoms in Men: A Korean Community Health Survey.

Authors:  Jung Ki Jo; Kyu Shik Kim; Ji Won Nam; Bo Yul Choi; Hong Sang Moon
Journal:  Int Neurourol J       Date:  2017-06-21       Impact factor: 2.835

7.  Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain.

Authors:  José María Molero; Bernardino Miñana; Juan Manuel Palacios-Moreno; Miguel Téllez Martínez-Fornes; David Lorite Mingot; Alfonso Agra Rolán; Ágata Carreño; Rafael Cuervo Pinto
Journal:  Int J Clin Pract       Date:  2020-08-16       Impact factor: 3.149

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.